Quality & Science

  • January 14, 2021

    ASAM Quality and Science Committee Updates

    ASAM’s Quality Improvement Council (QIC) has convened a new subcommittee called the Terminology and Definitions (TAD) Subcommittee, ASAM’s Quality Improvement Council (QIC) has convened a new subcommittee called the Clinical Practice Guideline (CPG) Oversight and Methodology Subcommittee, ASAM will be working in partnership with the National Commission on Correctional Health Care (NCCHC) to develop clinical guidelines and protocols for withdrawal management in jail-based settings.
  • January 14, 2021

    The Journal of Addiction Medicine Welcome Three New Editorial Fellows

    Given the significant increase in Journal submissions, the stress COVID-19 has put on our co-editors, and number of excellent candidates, third Fellow added to the program.
  • December 16, 2020

    Peers Speak Out: Improving Substance Use Treatment Outcomes During COVID-19

    Patients Lead: Identifying Meaningful Outcomes to Drive Substance UseDisorders Research and Care – Preliminary Findings and Full Report


Advocacy and Policy

Other News

ASAM Weekly Commentary

  • February 22, 2021

    Editorial Comment 2/23/2021: A Brutal And Heedless Sky

    Last week carried the hope of a real holiday, Presidents’ Day; or at least one for the Feds, with the possibility of a trickle-down effect. But by Wednesday, any elation experienced at the prospect of a four-day workweek had been blown either into the Gulf of Mexico or across the Great Lakes by a fierce and unrelenting winter assault. My words of sympathy to colleagues in virtual conferences or just on telephone calls most likely sounded taunting, even micro-aggressive. How could it not? With our own winter weather in Hawai`i dropping at night down to 69°, we’ve not a lot of justification for lamentation. - Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
  • February 16, 2021

    Editorial Comment 2/16/2021: Prescriptive Discretion and Buprenorphine

    The final selection below addresses the recent effort on the part of the Department of Health and Human Services to remove specific training requirements for the prescription of buprenorphine, for physicians. As most will be aware, that plan has been suspended subject to further review, but remains alive. The central focus of the article – actually an op-ed piece in The Hill - is on the distinction drawn between physicians and others with prescriptive authority (advanced practice registered nurses and physician assistants). The CARA act of 2016 requires both classes of providers to undergo training in addition to that normally required for obtaining or maintaining a DEA license for the prescription of controlled substances. Presently, the training requirement is significantly greater (3-fold) for non-physicians. The mandate was originally in recognition of the newer indication beyond analgesia for buprenorphine, for opioid use disorder. It was as well a concession to those who contended that, without some form of interpersonal therapy, the medication alone was inadequate. - Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
  • February 9, 2021

    Editorial Comment 2/9/2021: Sometimes We Get To Be Gunga Din. Sometimes We Thirst.

    This week’s abstracts all made really good reading; fortunately so, as that will balance the notable absence of a thoughtful editorial. - Editor-in-Chief: Dr. William Haning, MD, DFAPA, DFASAM
MOC Guide

Considering a Career in Addiction Medicine?

Physicians who have a primary ABMS board may apply to take the ABPM Addiction Medicine exam to become or continue to be an addiction medicine specialist. Get the latest updates click here.


Board Exam Study Tool

The ASAM Board Examination Study Tool (BEST) helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format. Includes over 700 board-style self-assessment questions and developed, reviewed and mapped to the ABPM exam blueprint content areas by national experts. Learn More>>>

Alcohol withdrawl management

Guideline on Alcohol Withdrawal Management

The ASAM Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome.

JAM Podcast

Journal of Addiction Medicine March/April 2020

In episode sixteen of Addiction Medicine: Beyond the Abstract, we are joined by Itai Danovitch, MD, MBA. He is the chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. In his paper, Dr. Danovitch discusses some of the challenges facing the study of opioid overdose events in the hospital setting. Click to listen